Podcast Feeds

Podcast: Dr. Allan Jarvis, sanofi pasteur

Posted by nruediger on March 31, 2010 at 9:25am EDT

Dr. Allan Jarvis, vice president of corporate development at sanofi pasteur, discusses the vaccine track that they are sponsoring at this year's BIO International Convention, the type of partnerships that they're currently seeking, how important the Convention is to their partnering efforts, among other things. For more information on sanofi pasteur, please visit www.sanofipasteur.com.

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Podcast: Bioethics and the Biotech Industry at the 2010 BIO International Convention

Posted by nruediger on March 26, 2010 at 2:39pm EDT

Michael Werner, a partner at Holland & Knight law firm, discusses ethical issues facing biotechnology today and the session he is organizing on bioethics and business practices for the 2010 BIO International Convention.

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

BioBytes: Biotechnology and Vaccines

Posted by ecreese on February 2, 2010 at 9:53am EST

New vaccines employing biotech innovations are changing the way we prevent illness.  Dr. Targan explains how biotech researchers are discovering new ways to prevent illnesses such as HPV, hepatitis-B, meningitis, and even the flu through new and improved research, manufacturing, and delivery mechanisms.

Download to listen or view the podcast.

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

BioDigest: Patient Advocacy

Posted by ecreese on January 27, 2010 at 10:48am EST

Patient advocacy groups have many different roles.  They are educators, they provide a support system for individuals and families of people living with illness, they lobby for increased research, and are increasingly providing funding to biotech companies to encourage further research and development of promising, and potentially life-saving therapies.  At the 2009 BIO International Convention, we met with patients  and patient advocates to learn more about how advocacy groups are working together with biotech researchers to promote innovative research and creation of therapies that may one d

BioBytes: Biotechnology and Endangered Animals

Posted by ecreese on January 12, 2010 at 10:19am EST

What do pandas, bantengs, and panthers have in common?  Their populations have all been assisted by biotechnology.  Whether endangered, or unhealthy due to a lack of biodiversity, advances in biotechnology - including animal cloning and assisted reproductive technologies, have helped these animals, and many others, to increase their populations, become healthier, and enjoy a more genetically diverse environment.

 

 

 

Download to listen or view the podcast.

Syndicate content